Overview
- ACO Name and Location
- ACO Primary Contact
- Organizational Information
- Shared Savings and Losses
- Quality Performance Results
ACO Name and Location
MD Valuecare, LLC
8001 Franklin Farms Drive, Suite 130
Richmond, VA 23229
ACO Primary Contact
Shannon Lodge, ACO Administrator
8001 Franklin Farms Drive, Suite 130
Richmond VA 23229
804-306-3478
[email protected]
Organizational Information
ACO Participants
| ACO Participants | ACO Participant in Joint Venture |
|---|---|
| Commonwealth Primary Care | N |
| Virginia Diabetes and Endocrinology | N |
ACO Governing Body
| Member First Name | Member Last Name | Member Title/Position | Member's Voting Power | Membership Type | ACO Participant Legal Business Name, if applicable |
|---|---|---|---|---|---|
| Cathy | Cawley | Manager | 12.5% | ACO Participant | Commonwealth Primary Care |
| Larry | Gooss, MD | Manager | 12.5% | ACO Participant | Commonwealth Primary Care |
| Rachel | Downey | Board Vice Chair, Manager | 12.5% | Other Representative | |
| Shea | Puttkammer, MD | Manager | 12.5% | ACO Participant | Virginia Diabetes and Endocrinology |
| Bert | Wilson | Manager | 12.5% | Medicare Beneficiary Representative | |
| R. Ward | Morgan, MD | Manager | 12.5% | ACO Participant | Commonwealth Primary Care |
| Stephen | Young, MD | Board Chair, Manager | 12.5% | ACO Participant | Virginia Diabetes and Endocrinology |
| J. Ken | Zelenak, MD | Manager | 12.5% | ACO Participant | Commonwealth Primary Care |
Key Clinical and Administrative Leadership
- ACO Executive: Shannon Lodge, MHA
- Medical Director: J. Ken Zelenak, MD
- Compliance Officer: Shannon Lodge, MHA
- Quality Assurance/Improvement Officer: J. Ken Zelenak, MD
ACO Committees and Committee Leadership
| Committee Name | Committee Leader Name and Position |
|---|---|
| Quality Committee | J. Ken Zelenak, MD - Chair |
| Managing Committee | Rachel Downey - Chair |
Types of ACO Participants, or Combinations of Participants, that Formed the ACO
Network of individual practices of ACO professionals.
Shared Savings and Losses
Amount of Shared Savings and Losses
Third Agreement Period
- Performance Year 2024, $5,460,950
- Performance Year 2023, $6,216,175
- Performance Year 2022, $4,654,763
- Performance Year 2021, $4,619,483
- Performance Year 2020, $1,894,328
Second Agreement Period
- Performance Year 2019, $0
- Performance Year 2018, $0
- Performance Year 2017, $3,701,488
First Agreement Period
- Performance Year 2016, $1,809,663
- Performance Year 2015, $0
- Performance Year 2014, $0
How Shared Savings Are Distributed
Third Agreement Period
Performance Year 2024
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 80%
Performance Year 2023
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 80%
Performance Year 2022
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 15%
- Proportion of distribution to ACO participants: 75%
Performance Year 2021
- Proportion invested in infrastructure: 11%
- Proportion invested in redesigned care processes/resources: 15%
- Proportion of distribution to ACO participants: 74%
Performance Year 2020
- Proportion invested in infrastructure: 25%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 65%
Second Agreement Period
Performance Year 2019 – N/A
Performance Year 2018 – N/A
Performance Year 2017
- Proportion invested in infrastructure: 41%
- Proportion invested in redesigned care processes/resources: 10%
- Proportion of distribution to ACO participants: 49%
First Agreement Period
Performance Year 2016
- Proportion invested in infrastructure: 100%
- Invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 0%
Performance Year 2015 – N/A
Performance Year 2014 – N/A
Quality Performance Results
2024 Quality performance results are based on CMS Web Interface Measure Set
| Measure # | Measure Name | Collection Type | Performance Rate | ACO Mean |
|---|---|---|---|---|
| 001 | Diabetes: Hemoglobin A1c (HbA1c) Poor Control | CMS Web Interface | 4.31 | 9.44 |
| 134 | Preventative Care and Screening: Screening for Depression and Follow-up Plan | CMS Web Interface | 94.03 | 81.46 |
| 236 | Controlling High Blood Pressure | CMS Web Interface | 87.29 | 79.49 |
| 318 | Screening for Future Fall Risk | CMS Web Interface | 99.19 | 88.99 |
| 110 | Preventative Care and Screening: Influenza Immunization | CMS Web Interface | 85.45 | 68.60 |
| 226 | Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention | CMS Web Interface | 80.00 | 79.98 |
| 113 | Colorectal Cancer Screening | CMS Web Interface | 88.44 | 77.81 |
| 112 | Breast Cancer Screening | CMS Web Interface | 86.31 | 80.93 |
| 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | CMS Web Interface | 90.42 | 86.50 |
| 370 | Depression Remission at Twelve Months | CMS Web Interface | 12.96 | 17.35 |
| CAHPS-1 | Getting Timely Care, Appointments, and Information | CAHPS | 78.05 | 83.07 |
| CAHPS-2 | How Well Providers Communicate | CAHPS | 92.43 | 93.96 |
| CAHPS-3 | Patient’s Rating of Provider | CAHPS | 90.75 | 92.43 |
| CAHPS-4 | Access to Specialists | CAHPS | 69.64 | 75.76 |
| CAHPS-5 | Health Promotion and Education | CAHPS | 70.37 | 65.48 |
| CAHPS-6 | Shared Decision Making | CAHPS | 62.89 | 62.31 |
| CAHPS-7 | Health Status and Functional Status | CAHPS | 75.89 | 74.14 |
| CAHPS-8 | Care Coordination | CAHPS | 85.53 | 85.89 |
| CAHPS-9 | Courteous and Helpful Office Staff | CAHPS | 92.51 | 92.89 |
| CAHPS-11 | Stewardship of Patient Resources | CAHPS | 28.18 | 26.98 |
| 479 * | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups | Administrative Claims | 0.1451 | 0.1517 |
| 484 * | Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions | Administrative Claims | --- | 37.00 |
*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance. *For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs’ providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.